Loading organizations...
§ Private Profile · San Mateo, CA, USA
Prealize Health is a technology company.
Prealize Health develops advanced predictive analytics solutions for the healthcare sector. Its core product provides accurate foresight into health outcomes, empowering proactive care management and strategic planning. The technical approach leverages sophisticated data models to forecast individual patient risks and population health trends, enhancing precision in healthcare decision-making.
Prealize’s journey began in 2015, stemming from foundational research at Stanford University. This inception was driven by the insight that advanced data science could transform healthcare from reactive to predictive and preventative strategies. While specific founder details are not available, the company’s academic origins underscore a commitment to scientific rigor.
The platform serves various entities within the healthcare ecosystem, including providers and payers, optimizing patient care and resource utilization. Prealize Health envisions a future where healthcare is managed with confidence and accuracy, transforming delivery. Their objective is to empower organizations to anticipate needs and improve health trajectories, fostering more effective, personalized health management.
Prealize Health has raised $28.1M across 2 funding rounds.
Prealize Health has raised $28.1M in total across 2 funding rounds.
Prealize Health is a Silicon Valley-based healthcare technology company that builds an AI-driven predictive analytics platform called MetisAI to transform reactive healthcare into proactive care. It serves health plans, providers, employers, specialty care management companies, and healthcare tech firms by solving key problems like inaccurate risk prediction, high costs, and inefficient resource allocation through precise forecasts of health events, financial risks, and member engagement.[1][2][4][6]
The platform delivers industry-leading accuracy (>80% in identifying rising cost and risk), enabling outcomes such as $30M in avoided medical spend for clients, 25% reduced inpatient admissions, 10% fewer ER visits, and $564 PMPM cost avoidance for engaged members. Growth momentum includes strategic partnerships like with Clarify Health (2024) for enhanced forecasting and the acquisition of CentraForce Health's Social Determinants of Health (SDoH) IP to create Comprehensive Determinants of Health™ insights.[2][4][6]
Prealize Health was founded in 2015 at Stanford University by Dr. Nigam Shah and Dr. Arnold Milstein, two industry thought leaders in clinical and care innovation. Their vision emerged from a desire to shift healthcare from reactive treatment to proactive prevention using AI and machine learning, drawing on Stanford's legacy of breakthroughs.[1][4][6]
Early traction built on assembling a team of healthcare leaders, data scientists, and engineers. The company evolved through continuous Stanford partnerships, launching a functional platform for analysts that identified rising-risk populations before issues escalated. Pivotal moments include proven results like cost savings for clients and expansions such as the CentraForce SDoH acquisition, enhancing holistic member profiles.[1][2][5][6]
Prealize stands out in healthcare analytics through these key strengths:
Prealize rides the AI-in-healthcare wave, capitalizing on trends like precision medicine and value-based care amid rising U.S. healthcare costs (projected to hit $6.8T by 2030). Timing is ideal post-COVID, with demand for predictive tools to handle utilization surges and health equity gaps.[2][4][6]
Market forces favoring it include explosive growth in healthcare AI (market to $188B by 2030) and payer/provider shifts to proactive models. Partnerships like Clarify Health amplify its reach, influencing the ecosystem by enabling precise interventions that cut costs 10-25% and improve outcomes for millions, while SDoH integration addresses social factors driving 80% of health.[4][6]
Prealize is poised for acceleration through MetisAI enhancements, deeper integrations, and expansions into personalized care via role-based UX and Comprehensive Determinants of Health™. Trends like multimodal AI, real-world evidence, and regulatory pushes for affordability will shape its path, potentially scaling to influence billions in savings.
As AI redefines healthcare precision, Prealize's Stanford roots and accuracy edge position it to lead the proactive shift—empowering organizations to not just predict, but prevent, for a healthier, more efficient future.
Prealize Health has raised $28.1M across 2 funding rounds. Most recently, it raised $22.0M Series B in April 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2019 | $22M Series B | John Doerr | Bonfire Ventures, Kleiner Perkins, Launchpad Venture Group, MediaLink, Anthony Saleh, Richard Branson, Blue Shield OF California, Guidewell, Premera Blue Cross | Announced |
| Sep 28, 2017 | $6.1M Series A | Arnold Milstein | John Espinola, Stanford | Announced |
Prealize Health has raised $28.1M in total across 2 funding rounds.
Prealize Health's investors include John Doerr, Bonfire Ventures, Kleiner Perkins, LaunchPad, MediaLink, Anthony Saleh, Richard Branson, Blue Shield of California, Guidewell, Premera Blue Cross, Arnold Milstein, John Espinola.